-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Coya Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2022 to Q2 2024.
- Coya Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.89M, a 6.58% increase year-over-year.
- Coya Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$10.1M, a 22.1% increase year-over-year.
- Coya Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$7.99M, a 34.8% increase from 2022.
- Coya Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$12.2M, a 150% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)